BMRN · ISSUER CIK 1048477
BIOMARIN PHARMACEUTICAL INC
Between Aug 1, 2026 and Oct 29, 2026, 3 BIOMARIN PHARMACEUTICAL INC insiders reported $0.00 of open-market purchases and $1.2M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.2MInsider selling
−$1.2MNet open-market
Oct 1, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202616:23 | Sep 30, 2026 | BMRN | EVP, Chief R&D Officer | F · Tax | $60.00 | −4,086 | 47,732 | -8% | $245K | ||
| Sep 14, 202618:55 | Sep 10, 2026 | BMRN | Director | A · Grant | — | +6,140 | 6,140 | New | — | ||
| Sep 3, 202618:41 | Sep 2, 2026 | BMRN | EVP, Chief Legal Officer | S · Sell | $66.28 | −17,557 | 61,003 | -22% | −$1.2M |